메뉴 건너뛰기




Volumn 35, Issue 9, 2017, Pages 963-967

Genomics of multiple myeloma

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

EID: 85016244924     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.70.6705     Document Type: Review
Times cited : (92)

References (44)
  • 1
    • 0028947460 scopus 로고
    • Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis
    • Läi JL, Zandecki M, Mary JY, et al: Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis. Blood 85:2490-2497, 1995
    • (1995) Blood , vol.85 , pp. 2490-2497
    • Läi, J.L.1    Zandecki, M.2    Mary, J.Y.3
  • 2
    • 0035496928 scopus 로고    scopus 로고
    • Hypodiploidy is a major prognostic factor in multiple myeloma
    • Smadja NV, Bastard C, Brigaudeau C, et al: Hypodiploidy is a major prognostic factor in multiple myeloma. Blood 98:2229-2238, 2001
    • (2001) Blood , vol.98 , pp. 2229-2238
    • Smadja, N.V.1    Bastard, C.2    Brigaudeau, C.3
  • 3
    • 0031035918 scopus 로고    scopus 로고
    • Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations
    • Calasanz MJ, Cigudosa JC, Odero MD, et al: Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations. Genes Chromosomes Cancer 18:84-93, 1997
    • (1997) Genes Chromosomes Cancer , vol.18 , pp. 84-93
    • Calasanz, M.J.1    Cigudosa, J.C.2    Odero, M.D.3
  • 4
    • 0030792866 scopus 로고    scopus 로고
    • The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization
    • Nishida K, Tamura A, Nakazawa N, et al: The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood 90:526-534, 1997
    • (1997) Blood , vol.90 , pp. 526-534
    • Nishida, K.1    Tamura, A.2    Nakazawa, N.3
  • 5
    • 0343355828 scopus 로고    scopus 로고
    • High incidence of translocations t (11;14) (q13;q32) and t (4; 14) (p16;q32) in patients with plasma cell malignancies
    • Avet-Loiseau H, Li JY, Facon T, et al: High incidence of translocations t (11;14) (q13;q32) and t (4; 14) (p16;q32) in patients with plasma cell malignancies. Cancer Res 58:5640-5645, 1998
    • (1998) Cancer Res , vol.58 , pp. 5640-5645
    • Avet-Loiseau, H.1    Li, J.Y.2    Facon, T.3
  • 6
    • 0141481984 scopus 로고    scopus 로고
    • The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma
    • Fonseca R, Debes-Marun CS, Picken EB, et al: The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma. Blood 102:2562-2567, 2003
    • (2003) Blood , vol.102 , pp. 2562-2567
    • Fonseca, R.1    Debes-Marun, C.S.2    Picken, E.B.3
  • 7
    • 0032147210 scopus 로고    scopus 로고
    • Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventionaldose chemotherapy
    • Drach J, Ackermann J, Fritz E, et al: Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventionaldose chemotherapy. Blood 92:802-809, 1998
    • (1998) Blood , vol.92 , pp. 802-809
    • Drach, J.1    Ackermann, J.2    Fritz, E.3
  • 8
    • 33847378314 scopus 로고    scopus 로고
    • Genetic abnormalities and survival in multiple myeloma: The experience of the Intergroupe Francophone du MyéLome
    • Avet-Loiseau H, Attal M, Moreau P, et al: Genetic abnormalities and survival in multiple myeloma: The experience of the Intergroupe Francophone du Myélome. Blood 109:3489-3495, 2007
    • (2007) Blood , vol.109 , pp. 3489-3495
    • Avet-Loiseau, H.1    Attal, M.2    Moreau, P.3
  • 9
    • 22044440425 scopus 로고    scopus 로고
    • Cyclin D dysregulation: An early and unifying pathogenic event in multiple myeloma
    • Bergsagel PL, Kuehl WM, Zhan F, et al: Cyclin D dysregulation: An early and unifying pathogenic event in multiple myeloma. Blood 106:296-303, 2005
    • (2005) Blood , vol.106 , pp. 296-303
    • Bergsagel, P.L.1    Kuehl, W.M.2    Zhan, F.3
  • 10
    • 0036493522 scopus 로고    scopus 로고
    • Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells
    • Zhan F, Hardin J, Kordsmeier B, et al: Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 99:1745-1757, 2002
    • (2002) Blood , vol.99 , pp. 1745-1757
    • Zhan, F.1    Hardin, J.2    Kordsmeier, B.3
  • 11
    • 10744221725 scopus 로고    scopus 로고
    • Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease
    • Magrangeas F, Nasser V, Avet-Loiseau H, et al: Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease. Blood 101:4998-5006, 2003
    • (2003) Blood , vol.101 , pp. 4998-5006
    • Magrangeas, F.1    Nasser, V.2    Avet-Loiseau, H.3
  • 12
    • 33745779502 scopus 로고    scopus 로고
    • The molecular classification of multiple myeloma
    • Zhan F, Huang Y, Colla S, et al: The molecular classification of multiple myeloma. Blood 108:2020-2028, 2006
    • (2006) Blood , vol.108 , pp. 2020-2028
    • Zhan, F.1    Huang, Y.2    Colla, S.3
  • 13
    • 77957733923 scopus 로고    scopus 로고
    • Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients
    • Broyl A, Hose D, Lokhorst H, et al: Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients. Blood 116:2543-2553, 2010
    • (2010) Blood , vol.116 , pp. 2543-2553
    • Broyl, A.1    Hose, D.2    Lokhorst, H.3
  • 14
    • 54249092519 scopus 로고    scopus 로고
    • Predictionof survivalinmultiple myeloma based ongene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: A study of the Intergroupe Francophone du MyéLome
    • Decaux O, Lodé L, Magrangeas F, et al: Predictionof survivalinmultiple myeloma based ongene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: A study of the Intergroupe Francophone du Myélome. J Clin Oncol 26:4798-4805, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 4798-4805
    • Decaux, O.1    Lodé, L.2    Magrangeas, F.3
  • 15
    • 33645769276 scopus 로고    scopus 로고
    • Highresolution genomic profiles define distinct clinicopathogenetic subgroups of multiple myeloma patients
    • Carrasco DR, Tonon G, Huang Y, et al: Highresolution genomic profiles define distinct clinicopathogenetic subgroups of multiple myeloma patients. Cancer Cell 9:313-325, 2006
    • (2006) Cancer Cell , vol.9 , pp. 313-325
    • Carrasco, D.R.1    Tonon, G.2    Huang, Y.3
  • 16
    • 74549190701 scopus 로고    scopus 로고
    • Prognostic significance of copy-number alterations in multiple myeloma
    • Avet-Loiseau H, Li C, Magrangeas F, et al: Prognostic significance of copy-number alterations in multiple myeloma. J Clin Oncol 27:4585-4590, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 4585-4590
    • Avet-Loiseau, H.1    Li, C.2    Magrangeas, F.3
  • 17
    • 34248201056 scopus 로고    scopus 로고
    • Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling
    • Chng WJ, Kumar S, Vanwier S, et al: Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling. Cancer Res 67:2982-2989, 2007
    • (2007) Cancer Res , vol.67 , pp. 2982-2989
    • Chng, W.J.1    Kumar, S.2    Vanwier, S.3
  • 18
    • 0030922231 scopus 로고    scopus 로고
    • Frequent translocation t (4;14) (p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
    • Chesi M, Nardini E, Brents LA, et al: Frequent translocation t (4;14) (p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260-264, 1997
    • (1997) Nat Genet , vol.16 , pp. 260-264
    • Chesi, M.1    Nardini, E.2    Brents, L.A.3
  • 19
    • 0032212243 scopus 로고    scopus 로고
    • The t (4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts
    • Chesi M, Nardini E, Lim RS, et al: The t (4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 92:3025-3034, 1998
    • (1998) Blood , vol.92 , pp. 3025-3034
    • Chesi, M.1    Nardini, E.2    Lim, R.S.3
  • 20
    • 0031839633 scopus 로고    scopus 로고
    • Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma
    • Chesi M, Bergsagel PL, Shonukan OO, et al: Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 91:4457-4463, 1998
    • (1998) Blood , vol.91 , pp. 4457-4463
    • Chesi, M.1    Bergsagel, P.L.2    Shonukan, O.O.3
  • 21
    • 1442285889 scopus 로고    scopus 로고
    • Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma
    • Hurt EM, Wiestner A, Rosenwald A, et al: Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell 5:191-199, 2004
    • (2004) Cancer Cell , vol.5 , pp. 191-199
    • Hurt, E.M.1    Wiestner, A.2    Rosenwald, A.3
  • 22
    • 0034935624 scopus 로고    scopus 로고
    • Ectopic expression of MAFB gene in human myeloma cells carrying (14;20) (q32;q11) chromosomal translocations
    • Hanamura I, Iida S, Akano Y, et al: Ectopic expression of MAFB gene in human myeloma cells carrying (14;20) (q32;q11) chromosomal translocations. Jpn J Cancer Res 92:638-644, 2001
    • (2001) Jpn J Cancer Res , vol.92 , pp. 638-644
    • Hanamura, I.1    Iida, S.2    Akano, Y.3
  • 23
    • 0035412392 scopus 로고    scopus 로고
    • Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma
    • Shaughnessy J Jr, Gabrea A, Qi Y, et al: Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma. Blood 98:217-223, 2001
    • (2001) Blood , vol.98 , pp. 217-223
    • Shaughnessy, J.1    Gabrea, A.2    Qi, Y.3
  • 24
    • 84951335681 scopus 로고    scopus 로고
    • Understanding the role of hyperdiploidy in myeloma prognosis: Which trisomies really matter?
    • Chretien ML, Corre J, Lauwers-Cances V, et al: Understanding the role of hyperdiploidy in myeloma prognosis: Which trisomies really matter? Blood 126:2713-2719, 2015
    • (2015) Blood , vol.126 , pp. 2713-2719
    • Chretien, M.L.1    Corre, J.2    Lauwers-Cances, V.3
  • 25
    • 84895803630 scopus 로고    scopus 로고
    • Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: The IFM experience on 1195 patients
    • Hebraud B, Leleu X, Lauwers-Cances V, et al: Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: The IFM experience on 1195 patients. Blood 28:675-679, 2014
    • (2014) Blood , vol.28 , pp. 675-679
    • Hebraud, B.1    Leleu, X.2    Lauwers-Cances, V.3
  • 26
    • 33748196399 scopus 로고    scopus 로고
    • Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: Incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation
    • Hanamura I, Stewart JP, Huang Y, et al: Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: Incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation. Blood 108:1724-1732, 2006
    • (2006) Blood , vol.108 , pp. 1724-1732
    • Hanamura, I.1    Stewart, J.P.2    Huang, Y.3
  • 27
    • 78149246124 scopus 로고    scopus 로고
    • Mutations in TP53 are exclusively associated with del (17p) in multiple myeloma
    • Lodé L, Eveillard M, Trichet V, et al: Mutations in TP53 are exclusively associated with del (17p) in multiple myeloma. Haematologica 95:1973-1976, 2010
    • (2010) Haematologica , vol.95 , pp. 1973-1976
    • Lodé, L.1    Eveillard, M.2    Trichet, V.3
  • 28
    • 84962219514 scopus 로고    scopus 로고
    • Deletions linked to TP53 loss drive cancer through p53-independent mechanisms
    • Liu Y, Chen C, Xu Z, et al: Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. Nature 531:471-475, 2016
    • (2016) Nature , vol.531 , pp. 471-475
    • Liu, Y.1    Chen, C.2    Xu, Z.3
  • 29
    • 84951020021 scopus 로고    scopus 로고
    • Revised International Staging System for multiple myeloma: A report from International Myeloma Working Group
    • Palumbo A, Avet-Loiseau H, Oliva S, et al: Revised International Staging System for multiple myeloma: A report from International Myeloma Working Group. J Clin Oncol 33:2863-2869, 2015
    • (2015) J Clin Oncol , vol.33 , pp. 2863-2869
    • Palumbo, A.1    Avet-Loiseau, H.2    Oliva, S.3
  • 30
    • 79951494668 scopus 로고    scopus 로고
    • Initial genome sequencing and analysis of multiple myeloma
    • Chapman MA, Lawrence MS, Keats JJ, et al: Initial genome sequencing and analysis of multiple myeloma. Nature 471:467-472, 2011
    • (2011) Nature , vol.471 , pp. 467-472
    • Chapman, M.A.1    Lawrence, M.S.2    Keats, J.J.3
  • 31
    • 84892699941 scopus 로고    scopus 로고
    • Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
    • Bolli N, Avet-Loiseau H, Wedge DC, et al: Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun 5:2997, 2014
    • (2014) Nat Commun , vol.5 , pp. 2997
    • Bolli, N.1    Avet-Loiseau, H.2    Wedge, D.C.3
  • 32
    • 84892409192 scopus 로고    scopus 로고
    • Widespread genetic heterogeneity in multiple myeloma: Implications for targeted therapy
    • Lohr JG, Stojanov P, Carter SL, et al: Widespread genetic heterogeneity in multiple myeloma: Implications for targeted therapy. Cancer Cell 25:91-101, 2014
    • (2014) Cancer Cell , vol.25 , pp. 91-101
    • Lohr, J.G.1    Stojanov, P.2    Carter, S.L.3
  • 33
    • 84928558756 scopus 로고    scopus 로고
    • APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma
    • Walker BA, Wardell CP, Murison A, et al: APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. Nat Commun 6:6997, 2015
    • (2015) Nat Commun , vol.6 , pp. 6997
    • Walker, B.A.1    Wardell, C.P.2    Murison, A.3
  • 34
    • 79959293462 scopus 로고    scopus 로고
    • BRAF mutations in hairy-cell leukemia
    • Tiacci E, Trifonov V, Schiavoni G, et al: BRAF mutations in hairy-cell leukemia. N Engl J Med 364:2305-2315, 2011
    • (2011) N Engl J Med , vol.364 , pp. 2305-2315
    • Tiacci, E.1    Trifonov, V.2    Schiavoni, G.3
  • 35
    • 84865475885 scopus 로고    scopus 로고
    • MYD88 L265P somatic mutation in Waldenström's macroglobulinemia
    • Treon SP, Xu L, Yang G, et al: MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. N Engl J Med 367:826-833, 2012
    • (2012) N Engl J Med , vol.367 , pp. 826-833
    • Treon, S.P.1    Xu, L.2    Yang, G.3
  • 36
    • 84882837534 scopus 로고    scopus 로고
    • Signatures of mutational processes in human cancer
    • Alexandrov LB, Nik-Zainal S, Wedge DC, et al: Signatures of mutational processes in human cancer. Nature 500:415-421, 2013
    • (2013) Nature , vol.500 , pp. 415-421
    • Alexandrov, L.B.1    Nik-Zainal, S.2    Wedge, D.C.3
  • 37
    • 84885640686 scopus 로고    scopus 로고
    • Erratum
    • [Erratum: Nature 502:258, 2013]
    • (2013) Nature , vol.502 , pp. 258
  • 38
    • 84947116451 scopus 로고    scopus 로고
    • Mutational spectrum, copy number changes, and outcome: Results of a sequencing study of patients with newly diagnosed myeloma
    • Walker BA, Boyle EM, Wardell CP, et al: Mutational spectrum, copy number changes, and outcome: Results of a sequencing study of patients with newly diagnosed myeloma. J Clin Oncol 33:3911-3920, 2015
    • (2015) J Clin Oncol , vol.33 , pp. 3911-3920
    • Walker, B.A.1    Boyle, E.M.2    Wardell, C.P.3
  • 39
    • 84911897497 scopus 로고    scopus 로고
    • Differential and limited expression of mutant alleles in multiple myeloma
    • Rashid NU, Sperling AS, Bolli N, et al: Differential and limited expression of mutant alleles in multiple myeloma. Blood 124:3110-3117, 2014
    • (2014) Blood , vol.124 , pp. 3110-3117
    • Rashid, N.U.1    Sperling, A.S.2    Bolli, N.3
  • 40
    • 84873565928 scopus 로고    scopus 로고
    • Minor clone provides a reservoir for relapse in multiple myeloma
    • Magrangeas F, Avet-Loiseau H, Gouraud W, et al: Minor clone provides a reservoir for relapse in multiple myeloma. Leukemia 27:473-481, 2013
    • (2013) Leukemia , vol.27 , pp. 473-481
    • Magrangeas, F.1    Avet-Loiseau, H.2    Gouraud, W.3
  • 41
    • 84864544413 scopus 로고    scopus 로고
    • Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t (4; 14) and t (11;14) myeloma
    • Walker BA, Wardell CP, Melchor L, et al: Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t (4; 14) and t (11;14) myeloma. Blood 120:1077-1086, 2012
    • (2012) Blood , vol.120 , pp. 1077-1086
    • Walker, B.A.1    Wardell, C.P.2    Melchor, L.3
  • 42
  • 43
    • 84893810104 scopus 로고    scopus 로고
    • Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms
    • Walker BA, Wardell CP, Melchor L, et al: Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms. Leukemia 28:384-390, 2014
    • (2014) Leukemia , vol.28 , pp. 384-390
    • Walker, B.A.1    Wardell, C.P.2    Melchor, L.3
  • 44
    • 84881490568 scopus 로고    scopus 로고
    • Targeting the BRAF V600E mutation in multiple myeloma
    • Andrulis M, Lehners N, Capper D, et al: Targeting the BRAF V600E mutation in multiple myeloma. Cancer Discov 3:862-869, 2013
    • (2013) Cancer Discov , vol.3 , pp. 862-869
    • Andrulis, M.1    Lehners, N.2    Capper, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.